tryptophan has been researched along with Progressive Tapetochoroidal Dystrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abbouda, A; Cunha, DL; Horneffer-van der Sluis, V; Mitsios, A; Moosajee, M; Owen, N; Richardson, R; Skinner, J; Takis, P; Tracey-White, D; Welch, AA | 1 |
1 other study(ies) available for tryptophan and Progressive Tapetochoroidal Dystrophy
Article | Year |
---|---|
REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia.
Topics: Adaptor Proteins, Signal Transducing; Adult; Animals; Case-Control Studies; Choroideremia; Fenofibrate; Glycerophospholipids; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipidomics; Male; Metabolomics; Middle Aged; Oxidative Stress; Prenylation; Serotonin; Simvastatin; Sphingolipids; Tryptophan; Young Adult; Zebrafish; Zebrafish Proteins | 2021 |